ID: ALA5076900

Max Phase: Preclinical

Molecular Formula: C42H70N14O10

Molecular Weight: 931.11

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O

Standard InChI:  InChI=1S/C42H70N14O10/c1-22(2)20-30(36(61)50-23(3)33(58)53-29(40(65)66)15-10-18-49-42(46)47)54-34(59)24(4)51-38(63)32(25(5)57)55-37(62)31-16-11-19-56(31)39(64)28(14-9-17-48-41(44)45)52-35(60)27(43)21-26-12-7-6-8-13-26/h6-8,12-13,22-25,27-32,57H,9-11,14-21,43H2,1-5H3,(H,50,61)(H,51,63)(H,52,60)(H,53,58)(H,54,59)(H,55,62)(H,65,66)(H4,44,45,48)(H4,46,47,49)/t23-,24+,25-,27+,28+,29+,30+,31+,32+/m1/s1

Standard InChI Key:  KOUJJFLKINMWCU-RGLNHWONSA-N

Associated Targets(Human)

C3a anaphylatoxin chemotactic receptor 750 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

C5a anaphylatoxin chemotactic receptor 2677 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 931.11Molecular Weight (Monoisotopic): 930.5399AlogP: -3.47#Rotatable Bonds: 27
Polar Surface Area: 402.26Molecular Species: ZWITTERIONHBA: 12HBD: 15
#RO5 Violations: 3HBA (Lipinski): 24HBD (Lipinski): 18#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.94CX Basic pKa: 11.61CX LogP: -6.08CX LogD: -8.12
Aromatic Rings: 1Heavy Atoms: 66QED Weighted: 0.02Np Likeness Score: 0.09

References

1. Gorman DM, Li XX, Lee JD, Fung JN, Cui CS, Lee HS, Rolfe BE, Woodruff TM, Clark RJ..  (2021)  Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity.,  64  (22.0): [PMID:34762432] [10.1021/acs.jmedchem.1c01174]

Source